BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15934816)

  • 1. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
    Fu K; Iqbal J; Chan WC
    Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling in lymphoma diagnosis and management.
    Iqbal J; Liu Z; Deffenbacher K; Chan WC
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):191-210. PubMed ID: 19698928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular diagnosis of malignant lymphomas].
    Holte H; Kvaløy S; Delabie J; Trøen G; Smeland EB
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2352-6. PubMed ID: 19935935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.
    Last K; Debarnardi S; Lister TA
    Methods Mol Med; 2005; 115():15-63. PubMed ID: 15998962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of gene expression profiling using cDNA arrays in lymphomas].
    Bertucci F; Salas S; Nasser V; Houlgatte R; Birnbaum D; Xerri L
    Bull Cancer; 2002; 89(7-8):661-5. PubMed ID: 12206978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA microarrays in lymphoid malignancies.
    Rosenwald A
    Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma.
    Wu G; Keating A
    Cancer; 2006 Jan; 106(2):247-57. PubMed ID: 16342164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual behavior of primary tonsillary lymphoma.
    Han U; Uner A; Yimazer D
    Am J Hematol; 2006 Aug; 81(8):644-5. PubMed ID: 16823817
    [No Abstract]   [Full Text] [Related]  

  • 12. Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics.
    Valet GK; Hoeffkes HG
    Cytometry A; 2004 Jun; 59(2):232-6. PubMed ID: 15170602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gene expression profiling in lymphoma diagnosis and prognosis.
    Orsborne C; Byers R
    Histopathology; 2011 Jan; 58(1):106-27. PubMed ID: 21261687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma.
    Barth TF; Barth CA; Kestler HA; Michl P; Weniger MA; Buchholz M; Möller P; Gress T
    J Pathol; 2007 Feb; 211(3):305-13. PubMed ID: 17152084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarkers in diffuse large B-cell lymphoma.
    Lossos IS; Morgensztern D
    J Clin Oncol; 2006 Feb; 24(6):995-1007. PubMed ID: 16418498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Logical analysis of diffuse large B-cell lymphomas.
    Alexe G; Alexe S; Axelrod DE; Hammer PL; Weissmann D
    Artif Intell Med; 2005 Jul; 34(3):235-67. PubMed ID: 16023562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffuse large cell lymphoma: new molecular approaches].
    Madrigal-Velázquez M; Avilés-Miranda A; Mayani H
    Rev Invest Clin; 2004; 56(4):483-94. PubMed ID: 15587295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression in diagnosis.
    Berns A
    Nature; 2000 Feb; 403(6769):491-2. PubMed ID: 10676943
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.